Activation of adenylate cyclase by human recombinant sst5 receptors expressed in CHO-K1 cells and involvement of G(αs) proteins

British Journal of Pharmacology

Volumn 126, Issue 5, 1999, Pages 1221-1229

  Carruthers, Alan M ^a   Warner, Andrea J ^a,b   Michel, Anton D ^a   Feniuk, Wasyl ^a   Humphrey, Patrick P A ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Adenylate cyclase; CHO K1 cells; Cholera toxin; G( s) proteins; Pertussis toxin; Somatostatin; sst5 receptor; 35S GTP S binding and immunoprecipitation

Indexed keywords

ADENYLATE CYCLASE; CHOLERA TOXIN; CYCLIC AMP; DEXTRO PHENYLALANYLPHENYLALANYLTYROSYL DEXTRO TRYPTOPHYLLYSYLVALYLPHENYLALANYL DEXTRO [3 (2 NAPHTHYL)ALANINAMIDE]; FORSKOLIN; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); L 362855; PERTUSSIS TOXIN; PROSTAGLANDIN E2; PROSTANOID RECEPTOR; SOMATOSTATIN 14; SOMATOSTATIN 28; SOMATOSTATIN RECEPTOR; SYNTHETIC PEPTIDE;

ANIMAL CELL; ARTICLE; CHO CELL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG POTENCY; GENETIC TRANSFECTION; NONHUMAN; PRIORITY JOURNAL;

EID: 0033014434     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702401     Document Type: Article

References (46)

1. 2+ mobilization by cloned human somatostatin receptor subtypes 1-5, in transfected COS-7 cells. FEBS Lett., 348, 192-196.
2. ASHKENAZI, A., WINSLOW, J.W., PERALTA, E.G., PETERSON, G.L., SCHIMERLIK, M.I., CAPON, D.J. & RAMACHANDRAN, J. (1987). An M2 muscarinic receptor subtype coupled to both adenylyl cyclase and phosphoinositide turnover. Science, 238, 672-675.
3. BARBER, D.L., MCGUIRE, M.E. & GANZ, M.B. (1989). β-adrenergic and somatostatin receptors regulate Na-H exchange independent of cAMP. J. Biol. Chem., 264, 21038-21042.
4. BAUMEISTER, H., KREUZER, O.J., ROOSTERMAN, D., SCHAFER, J. & MEYERHOF, W. (1998). Cloning, expression, pharmacology and tissue distribution of mouse somatostatin receptor subtype 5. J. Neuroendocrinol., 10, 283-290.
5. BERG, K.A., MAAYANI, S., GOLDFARB, J., SCARAMELLINI, C., LEFF, P. & CLARKE, W.P. (1998). Effector pathway-dependent relative efficacy at serotonin type 2A and 2C receptors: Evidence for agonist-directed trafficking of receptor stimulus. Mol. Pharmacol., 54, 94-104.
6. BITO, H., MORI, M., SAKANAKA, C., TAKANO, T., HONDA, Z., GOTOH, Y., NISHIDA, E. & SHIMIZU, T. (1994). Functional coupling of SSTR4, a major hippocampal somatostatin receptor, to adenylate cyclase inhibition, arachidonate release, and activation of the mitogen-activated protein kinase cascade. J. Biol. Chem., 269, 12722-12730.
7. BROWN, B.L., ALBANO, J.D.M., ELKINS, R.P., SGHERZI, A.M. & TAMPION, W. (1971) A simple and sensitive saturation assay method for the measurement of adenosine 3′,5′-cyclic monophosphate. Biochem. J., 121, 561-562.
8. sα and is not a consequence of phosphoinositide C activation. Biochem. J., 315, 883-888.
9. BURFORD, N.T., TOBIN, A.B. & NAHORSKI, S.R. (1995). Differential coupling of m1, m2 and m3 muscarinic receptor subtypes to inositol-1,4,5-trisphosphate and adenosine 3′,5′-cyclic monophosphate accumulation in Chinese hamster ovary cells. J. Pharmacol. Exp. Ther., 274, 134-142.
10. BURFORD, N.T., TOLBERT, L.M. & SADEE, W. (1998). Specific G protein activation and μ-opioid receptor internalization caused by morphine, DAMGO and endomorphin I. Eur. J. Pharmacol., 342, 123-126.
11. 2 receptor-dependent potentiation of arachidonic acid release. J. Neurochem., 59, 379-382.
12. s. Mol. Pharmacol., 45, 696-702.
13. 2-adrenergic receptors to two G-proteins with opposing effects. J. Biol. Chem., 267, 15795-15801.
14. i-protein beta gamma subunits. Nature, 356, 159-161.
15. 2-adrenergic receptor in Chinese hamster ovary cells. J. Biol. Chem., 264, 11754-11761.
16. s-stimulated adenylyl cyclases. FASEB. J., 7, 768-775.
17. JAKOBS, K.H., AKTORIES, K. & SCHULTZ, G. (1983). A nucleotide regulatory site for somatostatin inhibition of adenylate cyclase in S49 lymphoma cells. Nature, 303, 177-178.
18. JONES, D.T. & REED, R.R. (1987). Molecular cloning of five GTP-binding protein cDNA species from rat olfactory neuroepithilium. J. Biol. Chem., 262, 14241-14249.
19. JONES, S.V.P., HEILMAN, C.J. & BRANN, M.R. (1991). Functional responses of cloned muscarinic receptors expressed in CHO-K1 cells. Mol. Pharmacol., 40, 242-247.
20. LEWIS, D.F., WEIGHT, F. & LUNI, A. (1986). A guanine nucleotide-binding protein mediating the inhibition of voltage-dependent calcium current by somatostatin in a pituitary cell line. Proc. Natl. Acad. Sci U.S.A., 83, 9035-9039.
21. MANDARINO, L., STENNER, D., BLANCHARD, W., NISSEN, S., GERICH, J., LING, N., BRAZEAU, P., BOHLEN, P., ESCH, F. & GUILLEMIN, R. (1981). Selective effects of somatostatin-14,-25 and -28 on in vitro insulin and glucagon secretion. Nature, 291, 76-77.
22. MARKSTEIN, R., STOCKLI, K.A. & REUBI, J.-C. (1989). Differential effects of somatostatin on adenylate cyclase as functional correlates for different brain somatostatin receptor subpopulations. Neurosci. Lett., 104, 13-18.
23. sα specifies coupling of receptors to stimulation of adenylyl cyclase. Science, 241, 448-451.
24. O'CARROLL, A.-M., LOLAIT, S.J., KONIG, M. & MAHAN, L.C. (1992). Molecular cloning and expression of a pituitary somatostatin receptor with preferential affinity for somatostatin-28. Mol. Pharmacol., 42, 939-946.
25. O'CARROLL, A.-M., RAYNOR, K., LOLAIT, S.J. & REISINE, T. (1994). Characterization of cloned human somatostatin receptor SSTR5. Mol. Pharmacol., 46, 291-298.
26. PANETTA, R., GREENWOOD, M.T., WARSZYNSKA, A., DEMCHYSHYN, L., DAY, R., NIZNIK, H.B., SRIKANT, C.B. & PATEL, Y.C. (1994). Molecular cloning, functional characterization, and chromosomal localisation of a human somatostatin receptor (somatostatin receptor type 5) with preferential affinity for somatostatin-28. Mol. Pharmacol., 45, 417-427.
27. PATEL, Y.C., GREENWOOD, M.T., WARSZYNSKA, A., PANETTA, R. & SRIKANT, C.B. (1994). All five cloned human somatostatin receptors (hSSTR1-5) are functionally coupled to adenylyl cyclase. Biochem. Biophys. Res. Comm., 198, 605-612.
28. RASENICK, M.M., WATANABE, M., LAZEREVIC, M.B., HATTA, S. & HAMM, H.E. (1994). Synthetic peptides as probes for G protein function. J. Biol. Chem., 269, 21519-21525.
29. RAYNOR, K., MURPHY, W.A., COY, D.H., TAYLOR, J.E., MOREAU, J., YASUDA, K., BELL, G.I. & REISINE, T. (1993). Cloned somatostatin receptors: identification of subtype-selective peptide and demonstration of high affinity binding of linear peptides. Mol. Pharmacol., 43, 838-844.
30. REISINE, T. & BELL, G.I. (1995). Molecular properties of somatostatin receptors. Neuroscience, 67, 777-790.
31. 2 activation in CHO cells carrying somatostatin receptor: Wortmannin-sensitive pathway to activate mitogen-activated protein kinase. Biochem. Biophys. Res. Comm., 205, 18-23.
32. SCHINDLER, M., HUMPHREY, P.P.A. & EMSON, P.C. (1996). Somatostatin receptors in the central nervous system. Prog. Neurobiol., 50, 9-47.
33. STRATHMANN, M.P. & SIMON, M.I. (1991). Gα12 and Gaα13 subunits define a fourth class of G protein α subunits. Proc. Natl. Acad. Sci. U.S.A., 88, 5582-5586.
34. TANG, W.J. & GILMAN, A.G. (1991). Type-specific regulation of adenylyl cyclase by G protein βγ subunits. Science, 254, 1500-1503.
35. TAYLOR, J.E., THEVENIAU, M.A., BASHIRZADEH, R., REISINE, T. & EDEN, PA. (1994). Detection of somatostatin receptor subtype 2 (SSTR2) in established tumors and tumor cell lines: Evidence for SSTR2 heterogeneity. Peptides, 15, 1229-1236.
36. 5 receptors expressed in CHO-K1 cells mediate increases in extracellular acidification by pertussis toxin-sensitive and -insensitive pathways. Br. J. Pharmacol., 117, 9P.
37. VARGA, E.V., STROPOVA, D., RUBENIK, M., WANG, M., LANDSMAN, R.S., ROESKE, W.R. & YAMAMURA, H.I. (1998). Identification of adenylyl cyclase isoenzymes in CHO and B82 cells. Eur. J. Pharmacol., 348, R1-R2.
38. VIGUERIER, N., TAHIN-JOUTI, N., AYRIL, A.M., CAMBILLAN, C., SCEMAMA, J.L., BASTIE, M.J., KRUHTESEN, S., ESTERIE, J.P., PAYDAYROL, L., SUSINI, C. & VAYSSE, N. (1989). Direct inhibitory effects of a somatostatin analogue, SMS 201-995, on AR4-2J cell proliferation via a pertussis toxin-sensitive guanosine triphosphate-binding protein-independent mechanism. Endocrinology, 124, 1017-1025.
39. i-like dopamine sites in rat striatum: Possible role in dopamine-mediated inositol phosphate formation. Mol. Pharmacol., 48, 988-994.
40. WARHURST, G., BARBEZAT, G.O., HIGGS, N.B., REYL-DESMAR, F., LEWIN, M.J.M., COY, D.H., ROSS, I. & GRIGOR, M.R. (1995). Expression of somatostatin receptor genes and their role in inhibiting Cl secretion in HT-29cl. 19A colonocytes. Am. J. Physiol., 269, G729-G736.
41. 5 receptors mediating activation of phosphoinositide metabolism. Br. J. Pharmacol., 121, 91-96.
42. 5 receptor. Br. J. Pharmacol., 118, 445-447.
43. 5 receptor couples to pertussis toxin-sensitive and -insensitive G-proteins. Br. J. Pharmacol., 119, 11P.
44. 35S]guanosine-5′-0-(3-thio)triphosphate binding: Agonist potencies and the influence of sodium chloride on intrinsic activity. Mol. Pharmacol., 51, 1060-1069.
45. YAMADA, Y., KAGIMOTO, S., KUBOTA, A., YASUDA, K., MASUDA, K., SOMEGA, Y., IHARA, Y., LI, Q., IMURA, H., SEINO, S. & SEINO, Y. (1993). Cloning, functional expression and pharmacological characterization of a fourth (hSSTR4) and a fifth (hSSTR5) human somatostatin receptor subtype. Biochem. Biophys. Res. Comm., 195, 844-852.
46. YAMASHITA, N., SHIBUYA, N. & OGATA, E. (1987). Hyperpolarisation of the membrane potential caused by somatostatin in dissociated human pituitary adenoma cells that secrete growth hormone. Proc. Natl. Acad. Sci. U.S.A., 83, 6198-6202.